Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Ovine Corticotropinreleasing Hormone Ocrh

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT00975078Phase 4CompletedPrimary

Test Predicting Adrenal Insufficiency in Volunteers Under Prednisone Treatment

NCT00001180Completed

Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency

Showing all 2 trials

Research Network

Common Treatments

  • Ovine Corticotropinreleasing Hormone Ocrh1
  • Adrenal Insufficiency Testing1
  • Prednisone1

Active Sponsors

  • University Hospital, Basel, Switzerland1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Related Conditions

  • Adrenal Gland Hyperfunction1
  • Healthy1
  • Cushings Syndrome1

Activity Timeline